Designates July 16, 2025, as Glioblastoma Awareness Day and urges increased public awareness, research, and collaboration to address glioblastoma. The resolution highlights the severity of glioblastoma, slow progress on new therapies, the need for biomarker testing and improved clinical research, and encourages use of and investment in the Glioblastoma Therapeutics Network to accelerate progress.